[1]陈新怡,曾梅艳,宋厚盼,等.左金丸抗幽门螺杆菌感染的分子网络调控机制研究[J].中国中医药信息杂志,2020,27(5):90-96.[doi:10.3969/j.issn.1005-5304.201905115]
 CHEN Xinyi,ZENG Meiyan,SONG Houpan,et al.Study on Molecular Network Regulation Mechanism of Zuojin Pills Against Helicobacter Pylori Infection[J].zhongguo zhongyiyao xinxi zazhi,2020,27(5):90-96.[doi:10.3969/j.issn.1005-5304.201905115]
点击复制

左金丸抗幽门螺杆菌感染的分子网络调控机制研究

参考文献/References:

[1] GU H. Role of flagella in the pathogenesis of Helicobacter pylori[J]. Curr Microbiol,2017,74(7):863-869.

[2] 张万岱,胡伏莲,萧树东,等.中国自然人群幽门螺杆菌感染的流行病学调查[J].现代消化及介入诊疗,2010,15(5):265-270.

[3] MALFERTHEINER P, MEGRAUD F, O’MORAIN C A, et al. Management of Helicobacter pylori infection - the Maastricht V/Florence Consensus Report[J]. Gut,2017,66(1):6-30.

[4] SAVOLDI A, CARRARA E, GRAHAM D Y, et al. Prevalence of antibiotic resistance in Helicobacter pylori:A systematic review and meta-analysis in World Health Organization regions[J]. Gastroenterology,2018,155(5):1372-1382.

[5] LIU W Z, XIE Y, LU H, et al. Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection[J]. Helicobacter,2018,23(2):e12475.

[6] 周祥羽,岳贺,李春苑,等.左金丸对胃热证大鼠炎症因子、氧化应激因子及凋亡因子的影响[J].中药与临床,2017,8(2):49-52.

[7] 张彦琼,李梢.网络药理学与中医药现代研究的若干进展[J].中国药理学与毒理学杂志,2015,29(6):883-892.

[8] 汝锦龙.中药系统药理学数据库和分析平台的构建和应用[D].杨凌:西北农林科技大学,2015.

[9] CHIN C H, CHEN S H, WU H H, et al. cytoHubba:identifying hub objects and sub-networks from complex interactome[J]. BMC Syst Biol,2014,8(Suppl 4):S11.

[10] PARRISH A R. Matrix metalloproteinases in kidney disease:role in pathogenesis and potential as a therapeutic target[J]. Prog Mol Biol Transl Sci,2017,148:31-65.

[11] McCUBREY J A, LERTPIRIYAPONG K, FITZGERALD T L. Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasis[J]. Adv Biol Regul,2017,63:32-48.

[12] CASEY S C, BAYLOT V, FELSHER D W. The MYC oncogene is a global regulator of the immune response[J]. Blood,2018,131(18):2007- 2015.

[13] KAO C Y, SHEU B S, WU J J. Helicobacter pylori infection:An overview of bacterial virulence factors and pathogenesis[J]. Biomed J,2016,39(1):14-23.

[14] 邹全明.幽门螺杆菌疫苗[J].科技导报,2016,34(13):31-39.

[15] 李瀚旻,严永祥,程思思.幽门螺杆菌的中医治疗与进展[J].中华中医药学刊,2014,32(9):2055-2057.

[16] 赵平,许浚,张铁军,等.“病-证-方-药”结合探析左金丸配伍的科学内涵[J].中国中药杂志,2011,36(23):3380-3385.

[17] LI Y, YAO J, HAN C, et al. Quercetin, inflammation and immunity[J]. Nutrients,2016,8(3):167.

[18] WANG K, FENG X, CHAI L, et al. The metabolism of berberine and its contribution to the pharmacological effects[J]. Drug Metab Rev,2017,49(2):139-157.

[19] ZHANG D, KE L, NI Z, et al. Berberine containing quadruple therapy for initial Helicobacter pylori eradication:An open-label randomized phase Ⅳ trial[J]. Medicine (Baltimore), 2017,96(32):e7697.

[20] 易文,覃鹏飞,石孟琼,等.左金丸合四逆散治疗肝郁脾虚型溃疡性结肠炎疗效及其对血清促炎因子和抗炎因子水平的影响[J].中药药理与临床,2017,33(2):165-167.

[21] 叶乃菁,刘宣,李琦.左金丸及其活性成分抗胃癌的实验研究进展[J].中华中医药杂志,2014,29(4):1162-1164.

[22] COSKUN M, SALEM M, PEDERSEN J, et al. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease[J]. Pharmacol Res,2013,76(1):1-8.

相似文献/References:

[1]万丽艳.加味六君子汤合三联疗法治疗幽门螺杆菌相关性胃炎临床研究[J].中国中医药信息杂志,2011,18(1):83.[doi:10.3969/j.issn.1005-5304.2011.01.040]
 [J].zhongguo zhongyiyao xinxi zazhi,2011,18(5):83.[doi:10.3969/j.issn.1005-5304.2011.01.040]
[2]郭 璇,伍参荣,王小娟,等.灭幽汤对幽门螺杆菌相关性胃炎小鼠胃黏膜组织NF-κB和IκBα表达的影响[J].中国中医药信息杂志,2010,17(11):27.
 [J].zhongguo zhongyiyao xinxi zazhi,2010,17(5):27.
[3]李妙兰,王有谦.中西医结合治疗消化性溃疡疗效观察[J].中国中医药信息杂志,2011,18(2):86.[doi:10.3969/j.issn.1005-5304.2011.02.041]
 [J].zhongguo zhongyiyao xinxi zazhi,2011,18(5):86.[doi:10.3969/j.issn.1005-5304.2011.02.041]
[4]王成喜,朱承晖,袁新国.黄芪和黄芩联合埃索美拉唑治疗幽门螺杆菌相关性胃炎的疗效评价[J].中国中医药信息杂志,2010,17(9):68.[doi:10.3969/j.issn.1005-5304.2010.09.033]
 [J].zhongguo zhongyiyao xinxi zazhi,2010,17(5):68.[doi:10.3969/j.issn.1005-5304.2010.09.033]
[5]王小娟,郭建生,李倩,等.灭幽汤对慢性胃炎幽门螺杆菌定植的影响[J].中国中医药信息杂志,2008,15(1):63.
[6]唐小梅,伍参荣.戊己水煎液对幽门螺杆菌诱导SGC-7901细胞分泌白细胞介素-8的作用[J].中国中医药信息杂志,2008,15(8):43.
 TANG Xiao-mei,WU Can-rong.Effect of Wuji Solution on Excreting Interleukin-8 of SGC-7901 Cells Infected with Helicobacter Pylori in Vitro[J].zhongguo zhongyiyao xinxi zazhi,2008,15(5):43.
[7]张声生,吴兵,牧童,等.960例慢性浅表性胃炎患者中医证候分布与发病季节、幽门螺杆菌感染、黏膜糜烂的关系研究[J].中国中医药信息杂志,2007,14(4):25.
 ZHANG Sheng-sheng,WU Bing,MU Tong,et al.Study on Relationships between Distribution Disciplines of Chronic Stomach Disease Syndromes and Onset Seasons, HP Infection and Mucosal Erosion in 960 Cases[J].zhongguo zhongyiyao xinxi zazhi,2007,14(5):25.
[8]黄柳向.柴蒲泻心汤治疗幽门螺杆菌相关性消化性溃疡65例[J].中国中医药信息杂志,2007,14(7):67.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(5):67.
[9]张秀刚,姜红玉,郑国启,等.荆花胃康胶丸与奥美拉唑三联疗法治疗幽门螺杆菌相关慢性胃炎疗效观察[J].中国中医药信息杂志,2005,12(4):67.
 [J].zhongguo zhongyiyao xinxi zazhi,2005,12(5):67.
[10]宋琳琳,姜力,朱婷婷,等.幽门螺杆菌根除效果与中医证型相关性研究[J].中国中医药信息杂志,2013,20(12):7.[doi:10.3969/j.issn.1005-5304.2013.12.004]
 SONG Lin-lin,JIANG Li,ZHU Ting-ting,et al.Relationship between Hp Eradication Effect and TCM Syndrome Types[J].zhongguo zhongyiyao xinxi zazhi,2013,20(5):7.[doi:10.3969/j.issn.1005-5304.2013.12.004]

备注/Memo

基金项目:国家自然科学基金(81703920);中国博士后科学基金(2019M662790);湖南省自然科学基金(2019JJ50442);湖南省中医药管理局科研一般项目(201780);湖南省大学生研究性学习和创新性实验计划(2017280、201908);湖南中医药大学校级科研基金(2018XJJJ28);湖南中医药大学青年教师科研基金(201610);湖南中医药大学中医学一流学科开放基金(2018ZYX20)

更新日期/Last Update:

2020-04-22